By age 50, roughly half of all men show visible signs of male pattern baldness, and by age 80 the figure climbs to about 80%, according to the National Library of Medicine. The condition has many names — androgenetic alopecia, MPB, hereditary hair loss — but the underlying biology is the same: genetically susceptible hair follicles miniaturize over time in response to dihydrotestosterone (DHT). Two FDA-approved medications and a maturing surgical option give most men real choices, though no treatment fully reverses advanced loss, and no product on the market is a guaranteed or permanent “cure.” What follows is a plain-language overview; it is educational and not a substitute for advice from a clinician who has examined you.
What Male Pattern Baldness Actually Is
Androgenetic alopecia is a progressive, hereditary form of hair loss driven by sensitivity of scalp follicles to DHT, a more potent metabolite of testosterone. Affected follicles shrink with each hair cycle, producing thinner, shorter, and lighter hairs until the follicle eventually stops producing visible hair entirely. The pattern is distinctive: a receding hairline at the temples and thinning at the crown, sparing the lower back and sides of the scalp, where follicles are largely DHT-resistant.
The American Academy of Dermatology notes that the process is largely cosmetic but can carry significant psychological weight. Studies in JAMA Dermatology have linked early hair loss with mood symptoms in some men, which intersects with broader men’s mental health considerations. Feeling distressed about hair loss is common and worth raising with a clinician — it does not mean the loss itself is dangerous.
What Causes It
Genetics drive about 80% of the variability in MPB risk, with both maternal and paternal inheritance patterns at play. The androgen receptor gene on the X chromosome is the strongest single contributor, but more than 280 genetic loci have been associated with risk in genome-wide association studies, including a large 2017 analysis in PLOS Genetics and subsequent, even larger datasets. The old idea that baldness comes strictly “from your mother’s father” is an oversimplification.
The hormonal trigger is DHT, produced when the 5-alpha reductase enzyme converts testosterone. Men with MPB do not necessarily have higher overall testosterone — their follicles simply respond more strongly to normal DHT levels. This is why finasteride, a 5-alpha reductase inhibitor, works: it reduces scalp DHT by roughly 60-70%.
Lifestyle factors play a smaller role. Smoking has been associated with accelerated loss in observational studies, and severe nutritional deficiencies (iron, vitamin D, protein) can compound thinning. Stress can trigger telogen effluvium — a separate, usually reversible shedding pattern — but does not directly cause androgenetic alopecia. Because these other factors can mimic or worsen hair loss, a proper evaluation matters before assuming the cause is purely genetic.
Stages of Hair Loss: The Norwood Scale
Dermatologists and hair restoration surgeons stage MPB using the Hamilton-Norwood scale, which runs from Type 1 (no significant loss) to Type 7 (only a band of hair around the sides and back). Stage 2 features mild temple recession; stage 3 marks the entry into clinically significant loss with deeper temple recession or early crown thinning. Stage 4 shows distinct frontal and crown thinning bridged by a strip of hair, while stages 5 through 7 reflect progressive merging and expansion of those bald zones.
Staging matters because it influences treatment expectations. Medications tend to work best in early-to-moderate stages, while hair transplant outcomes depend on a stable donor area, which is generally good even in stage 5-6 men, according to the International Society of Hair Restoration Surgery. Staging is a communication tool, not a rigid prognosis — progression speed varies widely between individuals.
Diagnosis
For most men, MPB can be diagnosed by visual exam and family history alone. Dermatologists may use dermoscopy (trichoscopy) to confirm hair shaft miniaturization and rule out alternative causes. Blood work is generally unnecessary unless atypical features suggest another diagnosis: thyroid disease, iron deficiency, syphilis, or autoimmune alopecia areata.
Diffuse thinning without the classic frontal-temporal pattern, sudden shedding, or scarring patches all warrant a different workup. Women presenting with similar concerns are evaluated for female pattern hair loss, which has overlapping but distinct biology and a different treatment path — an important reason not to self-diagnose from photos online.
Treatment Options
Two medications carry FDA approval for male pattern baldness: minoxidil and finasteride. Neither is a cure, and both work only for as long as you keep using them.
Topical minoxidil (2% and 5%) is available over the counter. Use it as directed — follow the label for the strength, amount, and frequency, and give it time, since maximum effect typically takes 6-12 months. In studies, topical 5% minoxidil produces visible regrowth in roughly 40-60% of users. Some men notice increased shedding in the first few weeks as follicles reset into a new growth cycle; this is usually temporary. Stop, and gains generally fade within 6-12 months.
Oral finasteride (typically 1 mg daily for hair loss) is a prescription medication and should be taken only under a prescriber’s direction. In randomized trials, it maintains or improves hair count in a large majority of men over 1-2 years. Several points are important to understand before starting it: it is not for women who are or may become pregnant — even handling crushed or broken tablets poses a theoretical exposure risk to a male fetus, so the tablets should be kept away from pregnant household members; a minority of men report sexual side effects such as reduced libido or erectile difficulty, which usually resolve on stopping but have been reported to persist in some cases; regulators including the FDA and the European Medicines Agency have, in recent years, updated labeling to reflect reports of mood changes; and finasteride lowers PSA (a prostate cancer screening marker) by roughly 50%, so tell any clinician ordering a PSA test that you take it, so the result can be interpreted correctly. As with topical minoxidil, results reverse if you stop, so it is framed as ongoing maintenance.
Low-dose oral minoxidil is an increasingly popular off-label, prescriber-directed option — it is not FDA-approved for hair loss. A 2025 international expert consensus published in JAMA Dermatology set out where it may help, how it is dosed, who should avoid it, and what monitoring is reasonable. Because it can cause fluid retention and unwanted body-hair growth in some people, dosing and follow-up are decisions for your prescriber, not for self-experimentation.
Combining topical minoxidil with finasteride tends to outperform either alone in head-to-head studies. A note of caution on compounded topical finasteride and multi-drug “custom” formulas sold online: the FDA issued a 2025 safety alert about compounded topical finasteride after adverse-event reports, and it has not evaluated the safety or effectiveness of those unapproved products. If you consider them, do so with a clinician and informed of their off-label, unapproved status.
Hair transplantation — primarily follicular unit excision (FUE) and follicular unit transplantation (FUT) — is the only treatment that produces permanent regrowth in the treated area. It works by relocating DHT-resistant follicles from the donor area to the thinning zones. Cost commonly runs $4,000 to $15,000 in the US and varies widely by graft count and geography, with results visible at roughly 9-12 months. Read more in our hair transplant guide.
Adjunctive therapies with weaker or mixed evidence include low-level laser therapy (some FDA-cleared devices), platelet-rich plasma (PRP) injections, and oral dutasteride (off-label, used by some specialists for non-responders to finasteride). For women with pattern hair loss, dermatologists sometimes use spironolactone off-label. Marketed options like exosomes, microneedling kits, and supplement blends have limited high-quality data; treat bold before-and-after claims skeptically and ask what the actual evidence is.
Prevention and Realistic Expectations
True prevention is not possible because the trigger is genetic. Early intervention, however, can make a meaningful difference. Men who start treatment at the first signs of recession often maintain a denser hairline than those who wait. Follicles that have already disappeared cannot be revived medically — they can only be replaced surgically.
A balanced diet, adequate iron and vitamin D, not smoking, and stress management all support the hair you still have. None of these will reverse androgenetic alopecia on their own, and no supplement has been shown to do so. Hair shed in the first 2-3 months of starting minoxidil or finasteride is usually a transient response of follicles entering a new growth cycle rather than a sign the treatment is failing.
When to See a Doctor
A visit to a board-certified dermatologist makes sense at the first noticeable thinning rather than after years of loss, because earlier treatment preserves more follicles. Sudden hair loss, patchy bald spots, scaling or itching of the scalp, and hair loss accompanied by other symptoms like fatigue, weight changes, or rashes should prompt evaluation for non-androgenetic causes.
For men considering surgery, an in-person consultation with an ISHRS-affiliated surgeon — and ideally more than one — helps set realistic expectations about graft counts, density, and long-term planning as remaining native hair continues to thin.
Frequently Asked Questions
At what age does male pattern baldness start?
It can begin any time after puberty. Roughly 25% of men start losing hair before age 30, and about half have noticeable loss by age 50. Earlier onset often correlates with more rapid progression, which is one reason to seek advice sooner rather than later.
Does wearing hats cause hair loss?
No. Hats do not cause androgenetic alopecia. Only extremely tight hairstyles worn long-term can cause traction alopecia, a separate and largely preventable form of hair loss.
Is male pattern baldness reversible?
Partially. Medications can regrow some miniaturizing hair and slow further loss, but follicles that have completely vanished do not return. Hair transplantation can permanently restore density in those areas using donor hair from the back and sides. No treatment restores a full adolescent hairline.
Can I stop finasteride once my hair grows back?
If you discontinue, the gains typically reverse within 6-12 months as DHT levels rebound. Most dermatologists frame finasteride as long-term maintenance rather than a finite course, similar to medication for blood pressure. Any decision to start, change, or stop it should be made with your prescriber. Other related medical conditions follow a similar chronic-care pattern.
The Bottom Line
Male pattern baldness is common, genetic, and progressive — but increasingly manageable. The earlier you act, the more hair you have to work with. FDA-approved medications stabilize loss for most men, combination therapy tends to outperform single agents, and surgical restoration is a legitimate option for those with stable donor areas. Be cautious with unproven supplements, devices, and unapproved compounded products, and start the conversation with a dermatologist sooner rather than later.
Medical disclaimer: This article is for general education and is not medical advice. It does not replace an evaluation by a qualified clinician who knows your history. Prescription treatments such as finasteride and low-dose oral minoxidil should be used only under a prescriber’s direction; over-the-counter topical minoxidil should be used according to its label. Finasteride is not for women who are or may become pregnant. Talk to a board-certified dermatologist or your doctor before starting, stopping, or changing any treatment, and seek prompt care for sudden, patchy, or symptomatic hair loss.
Sources
- MedlinePlus / U.S. National Library of Medicine — Androgenetic alopecia: medlineplus.gov
- American Academy of Dermatology — Hair loss: aad.org
- JAMA Dermatology (2025) — Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement: jamanetwork.com
- U.S. Food and Drug Administration (2025) — Safety communication on compounded topical finasteride hair-loss products: fda.gov
- International Society of Hair Restoration Surgery — Patient resources: ishrs.org